glp 1 naion Ozempic & Wegovy Lawsuits Small NAION Risk from GLP-1

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that acts on both pathways

According to Lillys statement, participants who transitioned from Wegovy to orforglipron maintained the majority of their prior weight loss, with an average weight regain of only 0.9 kilograms after switching

If you travel often, prioritize durability and convenience over price alone

Mental Health Concerns Like Suicidal Thoughts Mental health concerns became an issue of importance with GLP-1 agonists when the Food and Drug Administrations Adverse Event Reporting System received numerous reports of individuals who reported suicidal thoughts and ideations while taking GLP-1 agonist drugs

swelling of your face, lips, tongue, or throat

Note that while Ozempic and Wegovy contain the same main ingredient, only Wegovy is FDA-approved specifically for weight loss.Wegovy[2], Ozempic): Liraglutide ( GLP-1 receptor agonist